| Josefino Calibo Diaz, | |
|
400 E 3rd St, Duluth, MN 55805-1951 | |
| (218) 786-8364 | |
| Not Available |
| Full Name | Josefino Calibo Diaz |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 41 Years |
| Location | 400 E 3rd St, Duluth, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891723599 | NPI | - | NPPES |
| 442858700 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 44952 (Minnesota) | Secondary |
| 207R00000X | Internal Medicine | 44952 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Essentia Health Duluth | Duluth, MN | Hospital |
| Essentia Health St Mary's Medical Center | Duluth, MN | Hospital |
| St Marys Hospital Superior | Superior, WI | Hospital |
| The North Shore Estates Llc | Duluth, MN | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Polinsky Medical Rehabilitation Center | 0941377360 | 198 |
| The Duluth Clinic Ltd | 2567374283 | 932 |
News Archive
The Fiscal Times reports on medical miracles and their place in the national health care reform debate with a likely subheading: high health care costs.
Genethon, dedicated to designing and developing gene therapy products for rare diseases, received this Monday 30th of November the authorization from the ANSM, the French National Agency for Medicines and Health Products Safety, to start in France a multicentre international clinical trial for the treatment of Duchenne muscular dystrophy with product GNT 004.
New evidence by University of Alabama at Birmingham researchers that specific electromagnetic fields can safely block the proliferation of cancer cells and tumor growth may help refine a new, targeted therapy without any collateral damage.
Laboratory rats who breathed Beijing's highly polluted air gained weight and experienced cardio-respiratory and metabolic dysfunctions after three to eight weeks of exposure.
› Verified 2 days ago
| Entity Name | The Duluth Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902563638 PECOS PAC ID: 2567374283 Enrollment ID: O20031103000229 |
News Archive
The Fiscal Times reports on medical miracles and their place in the national health care reform debate with a likely subheading: high health care costs.
Genethon, dedicated to designing and developing gene therapy products for rare diseases, received this Monday 30th of November the authorization from the ANSM, the French National Agency for Medicines and Health Products Safety, to start in France a multicentre international clinical trial for the treatment of Duchenne muscular dystrophy with product GNT 004.
New evidence by University of Alabama at Birmingham researchers that specific electromagnetic fields can safely block the proliferation of cancer cells and tumor growth may help refine a new, targeted therapy without any collateral damage.
Laboratory rats who breathed Beijing's highly polluted air gained weight and experienced cardio-respiratory and metabolic dysfunctions after three to eight weeks of exposure.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Josefino Calibo Diaz, 400 E 3rd St, Duluth, MN 55805-1951 Ph: (218) 786-8364 | Josefino Calibo Diaz, 400 E 3rd St, Duluth, MN 55805-1951 Ph: (218) 786-8364 |
News Archive
The Fiscal Times reports on medical miracles and their place in the national health care reform debate with a likely subheading: high health care costs.
Genethon, dedicated to designing and developing gene therapy products for rare diseases, received this Monday 30th of November the authorization from the ANSM, the French National Agency for Medicines and Health Products Safety, to start in France a multicentre international clinical trial for the treatment of Duchenne muscular dystrophy with product GNT 004.
New evidence by University of Alabama at Birmingham researchers that specific electromagnetic fields can safely block the proliferation of cancer cells and tumor growth may help refine a new, targeted therapy without any collateral damage.
Laboratory rats who breathed Beijing's highly polluted air gained weight and experienced cardio-respiratory and metabolic dysfunctions after three to eight weeks of exposure.
› Verified 2 days ago
Nizar Najib Saleh, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Dr. Joseph J Martinelli, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 920 E 1st St, Ste P201, Duluth, MN 55805 Phone: 218-249-7970 | |
Gina Marie Slipka-marinos, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Dr. Abdurrahman M Hamadah, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 E Superior St Ste L201, Duluth, MN 55802 Phone: 218-249-5555 | |
Sarah Jane Nelson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Robert Dale Niedringhaus, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Thomas Edward Russ, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |